Abstract
Histone H3 covalent modifications driving response of BCR‐ABL1+ cells sensitive and resistant to imatinib to Aurora kinase inhibitor MK‐0457
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have